We are live on ! Find out more
IMA

ImageneBio Inc
IMA

54 hedge funds and large institutions have $63.9M invested in ImageneBio Inc in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 28 increasing their positions, 12 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 12

0.62% less ownership

Funds ownership: 6.22% → 5.6% (-0.62%)

7% less funds holding

Funds holding: 58 → 54 (-4)

25% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 8

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

55% less capital invested

Capital invested by funds: $142M → $63.9M (-$77.6M)

Holders
54
Holders Change
-4
Holders Change %
-6.9%
% of All Funds
0.79%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
6
Increased
28
Reduced
12
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BOCH
Blue Owl Capital Holdings
New York
+$5.31M
2
BI
BVF Inc
California
+$4.35M
3
BlackRock
BlackRock
New York
+$1.12M
4
NMC
NEA Management Company
Maryland
+$1.06M
5
O
OrbiMed
New York
+$960K

Top Sellers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
-$7.1M
2
ACP
Acuta Capital Partners
California
-$2.39M
3
AG
Artal Group
Luxembourg
-$2.31M
4
Verition Fund Management
Verition Fund Management
Connecticut
-$1.08M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$744K
Name Holding Trade Value Shares
Change 		Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$9.89M – – –
BI
2
BVF Inc
California
$9.4M +$4.35M +133,333 +50%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$8.24M -$744K -22,820 -6%
O
4
OrbiMed
New York
$6.97M +$960K +29,433 +11%
OFM
5
Omega Fund Management
Massachusetts
$4.43M – – –
BOCH
6
Blue Owl Capital Holdings
New York
$3.85M +$5.31M +162,801 New
BlackRock
7
BlackRock
New York
$3.66M +$1.12M +34,330 +28%
Vanguard Group
8
Vanguard Group
Pennsylvania
$3M +$467K +14,322 +13%
Verition Fund Management
9
Verition Fund Management
Connecticut
$2.61M -$1.08M -33,274 -23%
AG
10
Artal Group
Luxembourg
$1.97M -$2.31M -70,833 -46%
NMC
11
NEA Management Company
Maryland
$1.12M +$1.06M +32,381 +214%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$1.04M +$33K +1,013 +2%
State Street
13
State Street
Massachusetts
$809K +$37.2K +1,142 +3%
LCM
14
Laurion Capital Management
New York
$734K -$440K -13,504 -30%
SI
15
Sofinnova Investments
California
$716K +$673K +20,647 +214%
VPC
16
Vestal Point Capital
New York
$636K +$877K +26,889 New
Adage Capital Partners
17
Adage Capital Partners
Massachusetts
$567K -$326K -10,000 -29%
Barclays
18
Barclays
United Kingdom
$482K +$104K +3,176 +18%
Northern Trust
19
Northern Trust
Illinois
$470K +$110K +3,380 +20%
VVA
20
Vida Ventures Advisors
Massachusetts
$444K – – –
AFM
21
Anson Funds Management
Texas
$412K +$569K +17,443 New
Citadel Advisors
22
Citadel Advisors
Florida
$351K -$77.6K -2,380 -14%
BCM
23
Bridgeway Capital Management
Texas
$283K +$78.5K +2,409 +25%
Morgan Stanley
24
Morgan Stanley
New York
$270K +$330K +10,120 +773%
Ensign Peak Advisors
25
Ensign Peak Advisors
Utah
$178K – – –
1
2 3

IMA Hedge Fund Activity: Q4 2023 in Review

54 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q4 2023, worth a combined $63.9M — down 55% from $142M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of IMA and 6 opened new positions — a net loss of 2 holders — while 12 trimmed existing stakes and 28 added.

The largest buyer was Blue Owl Capital Holdings, opening a new position worth an estimated $5.31M. The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $7.1M sold.

  • 54 institutional investors held ImageneBio Inc (IMA) as of Q4 2023, down from 58 in Q3 2023.
  • Funds reported $63.9M of ImageneBio Inc stock for Q4 2023, down 55% quarter-over-quarter.
  • 6 funds opened new ImageneBio Inc positions in Q4 2023 and 8 closed out, a net change of -2 holders.
  • The largest ImageneBio Inc buyer in Q4 2023 was Blue Owl Capital Holdings, an estimated $5.31M added.
  • The largest ImageneBio Inc seller in Q4 2023 was Avoro Capital Advisors, an estimated $7.1M sold.

Based on aggregated 13F filings for Q4 2023.